Godavari Drugs Ltd vs Quest Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Godavari Drugs Ltd is ₹ 120.65 as of 12 Jun 15:30 . The P/E Ratio of Godavari Drugs Ltd changed from 8.4 on March 2021 to 15 on March 2025 . This represents a CAGR of 12.30% over 5 yearsThe P/E Ratio of Quest Laboratories Ltd changed from 12.4 on March 2025 to 12.4 on March 2025 . This represents a CAGR of 0.00% over 1 years The Market Cap of Godavari Drugs Ltd changed from ₹ 34.45 crore on March 2021 to ₹ 65.86 crore on March 2025 . This represents a CAGR of 13.84% over 5 yearsThe Market Cap of Quest Laboratories Ltd changed from ₹ 167.89 crore on March 2025 to ₹ 167.89 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Godavari Drugs Ltd for the Mar '26 is ₹ 33.41 crore as compare to the Dec '25 revenue of ₹ 22.45 crore. This represent the growth of 48.82% The revenue of Quest Laboratories Ltd for the Mar '26 is ₹ 31.1 crore as compare to the Dec '25 revenue of ₹ 31.18 crore. This represent the decline of -0.26% The ebitda of Godavari Drugs Ltd for the Mar '26 is ₹ 3.19 crore as compare to the Dec '25 ebitda of ₹ 2.75 crore. This represent the growth of 16% The ebitda of Quest Laboratories Ltd for the Mar '26 is ₹ 2.83 crore as compare to the Dec '25 ebitda of ₹ 7.48 crore. This represent the decline of -62.17% The net profit of Godavari Drugs Ltd changed from ₹ 1.63 crore to ₹ 1.29 crore over 8 quarters. This represents a CAGR of -11.04% The net profit of Quest Laboratories Ltd changed from ₹ 1.48 crore to ₹ 2.87 crore over 8 quarters. This represents a CAGR of 39.25% The Dividend Payout of Godavari Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Quest Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Godavari Drugs Ltd

Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates and fine chemicals catering to global life science industry.
It works a manufacturing plant at Nanded, Maharashtra, India.
Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand.
Company apart from its own products, explores continual opportunities for loan licence manufacturing with reputed multinational companies. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.

About Quest Laboratories Ltd

Quest Laboratories Limited was originally incorporated as 'Quest Laboratories Private Limited' vide Certificate of Incorporation dated June 01, 1998, with the Registrar of Companies, Gwalior.
Thereafter, the status of the Company changed to Public Limited and the name of Company was changed to 'Quest Laboratories Limited' vide fresh Certificate of Incorporation issued on January 23, 2024, by Centralised Processing Centre. The Company is engaged in manufacturing of pharmaceutical formulations including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more.
It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC).
The Company is an ISO 9001:2015 in accordance with the requirements Quality Management System standard.

FAQs for the comparison of Godavari Drugs Ltd and Quest Laboratories Ltd

Which company has a larger market capitalization, Godavari Drugs Ltd or Quest Laboratories Ltd?

Market cap of Godavari Drugs Ltd is 122 Cr while Market cap of Quest Laboratories Ltd is 165 Cr

What are the key factors driving the stock performance of Godavari Drugs Ltd and Quest Laboratories Ltd?

The stock performance of Godavari Drugs Ltd and Quest Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Godavari Drugs Ltd and Quest Laboratories Ltd?

As of June 15, 2026, the Godavari Drugs Ltd stock price is INR ₹120.65. On the other hand, Quest Laboratories Ltd stock price is INR ₹101.05.

How do dividend payouts of Godavari Drugs Ltd and Quest Laboratories Ltd compare?

To compare the dividend payouts of Godavari Drugs Ltd and Quest Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.